Search results for "probiotic"

showing 10 items of 200 documents

Competitive inhibition of three novel bacteria isolated from faeces of breast milk-fed infants against selected enteropathogens.

2013

Numerousin vitroandin vivostudies conducted using different probiotic micro-organisms have demonstrated their ability to interfere with the growth and virulence of a variety of enteropathogens. The reported beneficial effects of the use of probiotics to complement antibiotic therapy or prevent diarrhoea or gastrointestinal infection in infants have increased in recent years. In the present study, we demonstrated the capacity of supernatants obtained from three novel probiotics (Lactobacillus paracaseiCNCM I-4034,Bifidobacterium breveCNCM I-4035 andLactobacillus rhamnosusCNCM I-4036) isolated from the faeces of breastfed infants to inhibit the growth of enterotoxigenic and enteropathogenic (…

Salmonella typhimuriumSalmonellaTime FactorsLactobacillus paracaseived/biology.organism_classification_rank.speciesMedicine (miscellaneous)Shigella sonneiBiologymedicine.disease_causelaw.inventionMicrobiologyProbioticEnteropathogenic Escherichia coliFecesLactobacillus rhamnosuslawAntibiosismedicineEnterotoxigenic Escherichia coliHumansShigellaNutrition and DieteticsBifidobacterium breveMicrobial Viabilityved/biologyLacticaseibacillus rhamnosusProbioticsInfant NewbornHydrogen-Ion ConcentrationSalmonella typhiAntimicrobialbiology.organism_classificationGastroenteritisLactobacillusBreast FeedingSpainCulture Media ConditionedBifidobacteriumBacteriaThe British journal of nutrition
researchProduct

Selection of potential probiotic lactobacilli from pig feces to be used as additives in pelleted feeding

2006

Thirty-five isolates from pig feces were identified as Lactobacillus reuteri (12 strains), Lactobacillus mucosae (7), Lactobacillus plantarum (6), Lactobacillus kitasatonis (3), Lactobacillus rossiae (2), Lactobacillus ultunensis (2), Lactobacillus crispatus (2), and Lactobacillus intestinalis (1) by partial sequence analysis of the 16S rRNA. All isolates were detected at 8-9 log CFU g(-1). Preliminarily, strains were selected based on resistance to heat treatments (ca. 70 degrees C for 10 s). The decrease in viability for some L. reuteri, L. mucosae, L. plantarum, L. kitasatonis, and L. rossiae strains was lower than 1 log cycle. Selected strains were further characterized for acid and bil…

Salmonella typhimuriumfood.ingredientSwineLactobacillus mucosaeMicrobiologylaw.inventionBile Acids and SaltsHeatingFeci suine mangimi probioticiFecesProbioticfoodlawRNA Ribosomal 16SLactobacillusAntibiosisSkimmed milkEscherichia coliAnimalsFood scienceMolecular BiologyMicrobial ViabilitybiologyLactobacillus crispatusProbioticsAdditivesfood and beveragesPelleted feedingGeneral MedicineLactobacillaceaeHydrogen-Ion ConcentrationPig fecesbiology.organism_classificationAnimal FeedLactobacillus reuteriLactobacillusFreeze DryingLactobacillus plantarumSettore AGR/16 - Microbiologia AgrariaResearch in Microbiology
researchProduct

PROBIOTICS: IN SICKNESS AND IN HEALTH

2018

Settore BIO/17 - IstologiaPROBIOTIC BACTEREMIA CANCER LACTOBACILLUS OPPORTUNISTIC INFECTIONS MICROBIOTA
researchProduct

Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights

2013

Inflammatory bowel disease (IBD) consists of two distinct clinical forms, ulcerative colitis (UC) and Crohn's disease (CD), with unknown aetiology, which nevertheless are considered to share almost identical pathophysiological backgrounds. Up to date, a full coherent mechanistic explanation for IBD is still lacking, but people start to realize that the pathogenesis of IBD involves four fundamental components: the environment, gut microbiota, the immune system and the genome. As a consequence, IBD development might be due to an altered immune response and a disrupted mechanism of host tolerance to the non-pathogenic resident microbiota, leading to an elevated inflammatory response. Consideri…

Settore BIO/17 - IstologiaPrebioticsMicrobiotaProbioticsHumansProbiotics Prebiotics Synbiotics Inflammatory Bowel DiseaseInflammatory Bowel Diseases
researchProduct

THE ROLE OF BUTYRIC ACID AS A OPROTECTIVE AGENT AGAINST INFLAMMATORY BOWEL DISEASE

2014

Inflammatory Bowel disease (IBD), such as Crohn's disease and ulcerative colitis, are pathologies characterized by a chronic inflammation of the gastrointestinal tract. Their etiopathogenesis is not yet fully understood. Immune system and heat shock proteins (HSPs) dysfunctions are considered to be among the most likely causes of these diseases. Butyrate is a short-chain fatty acid produced by intestinal microflora. It has a trophic, benefical and protective role in the colonic mucosa, and it also induces changes in Hsp levels and localization. It may therefore be a valuable complementary therapeutic agent when used alongside trraditional drugs (mesalazine and corticosteroids) to treat the …

Settore BIO/17 - IstologiaSettore MED/18 - Chirurgia GeneraleSettore MED/07 - Microbiologia E Microbiologia ClinicaSettore MED/09 - Medicina InternaSettore BIO/06 - Anatomia Comparata E Citologiainflammatory bowel disease butyruic acid microbiota probiotics
researchProduct

From gut microflora imbalance to mycobacteria infection: is there a relationship with chronic intestinal inflammatory diseases?

2011

The gut of a healthy adult harbours a myriad of different microbial species. It is estimated that approximately 10 14 are present in total bacterial colony forming units (CFU). Each colony colonizes a specific intestinal tract. In healthy adult, the main control of intestinal bacterial colonization occurs through gastric acidity but also other factors can influence the intestinal microenvironment such as pH, temperature, competition among different bacterial strains, peristalsis, drugs, radiotherapy and much more. Impaired microbial homeostasis leads to an alteration of the permeability of tissue, together with the activation of the intestinal immune system MALT (mucosal associated lymphoid…

Settore MED/07 - Microbiologia E Microbiologia ClinicaProbioticsMycobacterium Infections NontuberculousNontuberculous MycobacteriaInflammatory Bowel DiseasesSettore MED/18 - Chirurgia GeneraleTreatment OutcomeCrohn DiseaseRisk FactorsChronic DiseaseHumansColitis Ulcerativeintestinal microflora imbalance intestinal immune system chronic intestinal diseases mycobacteria probioticsIntestinal MucosaAnnali italiani di chirurgia
researchProduct

The Gliadin Hydrolysis Capacity of B. longum, L. acidophilus, and L. plantarum and Their Protective Effects on Caco-2 Cells against Gliadin-Induced I…

2023

Background: Non-celiac wheat sensitivity (NCWS) is a poorly understood gluten-related disorder (GRD) and its prominent symptoms can be ameliorated by gluten avoidance. This study aimed to determine the effectiveness of a probiotic mixture in hydrolyzing gliadin peptides (toxic components of gluten) and suppressing gliadin-induced inflammatory responses in Caco-2 cells. Methods: Wheat dough was fermented with a probiotic mix for 0, 2, 4, and 6 h. The effect of the probiotic mix on gliadin degradation was monitored by SDS-PAGE. The expression levels of IL-6, IL-17A, INF-G, IL-10, and TGF-B were evaluated using ELISA and qRT-PCR methods. Results: According to our findings, fermenting wheat dou…

Settore MED/09 - Medicina Internanon-celiac wheat sensitivitygliadinCaco-2 cellsprobiotic
researchProduct

DYSMICROBISM, INFLAMMATORY BOWEL DISEASE AND THYROIDITIS: ANALYSIS OF THE LITERATURE

2015

The human body is colonized by a large number of microbes that are collectively referred to as the microbiota. They interact with the hosting organism and some do contribute to the physiological maintenance of the general good health thru regulation of some metabolic processes while some others are essential for the synthesis of vitamins and short-chain fatty acids. The abnormal variation, in the quality and/or quantity of individual bacterial species residing in the gastro-intestinal tract, is called “dysmicrobism”. The immune system of the host will respond to these changes at the intestinal mucosa level which could lead to Inflammatory Bowel Diseases (IBD). This inflammatory immune respo…

Settore MED/12 - GastroenterologiaSettore MED/09 - Medicina InternaLymphoid TissueMicrobiotaProbioticsMolecular MimicryThyroiditis AutoimmuneThiamine DeficiencyInflammatory Bowel DiseasesGastrointestinal TractMiceSettore MED/18 - Chirurgia GeneraleBacterial TranslocationFermentationAutoimmune Thyroiditis Inflammatory Bowel Diseases dysmicrobisAnimalsGerm-Free LifeHumansIntestinal MucosaSymbiosis
researchProduct

I PROBIOTICI NEL TRATTAMENTO COMPLEMENTARE DELLE PATOLOGIE GASTRICHE

2017

Settore MED/12 - Gastroenterologiaprobiotici microbiota disbiosi
researchProduct

ASPETTI CLINICI DELLA MALATTIA DIVERTICOLARE

2013

La malattia diverticolare è una patologia piuttosto frequente nella popolazione occidentale. E' stimato che il 30-40% dei pazienti sottoposti ad indagini strumentali sull'apparato digerente presentino diverticoli al colon. Questi, nel 75% dei casi sono del tutto asintomatici. la diverticolosi appare strettamente connessa allo stile di vita ed alle abitudini alimentari tipiche dei paesi occidentali. a seguito di questa preferenza geografica, gli autori anglosassoni definiscono questa condizione patologica "a disease of western civilization". La diverticolosi insorge solitamente nei soggetti adulti, il trend della malattia aumenta proporzionalmente con l'età; pur tuttavia, negli ultimi anni a…

Settore MED/18 - Chirurgia GeneraleSettore MED/09 - Medicina InternaSettore MED/08 - Anatomia PatologicaMALATTIA DIVERTICOLAREMICROBIOTA INTESTINALE IBD PROBIOTICI
researchProduct